u/dario_vermeulen
Contributes reviews on supplier material. Based in Monterrey.
member · joined 16 Jul 2025
Overview — page 3 of 4
comment on what changed for me between week 75 and week 29 in c/glp1canada · 2 points · 1 year ago
Yeah, Australia coverage is not Australia coverage.
comment on genuine question about secretagogue that I am slightly embarrassed to ask in c/researchpeptides · 1 points · 1 year ago
I am going to push back on this slightly.
comment on small win: GIP stopped being a problem at week 41 in c/tirzepatide · 125 points · 1 year ago
the 15mg is the top of the pen, not the required dose
comment on [Question] Ireland — has anyone got a straight answer on private plan in c/glp1canada · 217 points · 1 year ago
provincial formularies differ sharply
comment on certificate of analysis: the version I wish someone had shown me in week 1 in c/coa · 1 points · 1 year ago
purity and net content are two different numbers, same vial
comment on [Question] Poland — has anyone got a straight answer on province in c/glp1canada · 37 points · 1 year ago
You have restated the marketing copy. What is the actual substance here.
comment on small win: tapering stopped being a problem at week 30 in c/tapering · 11 points · 1 year ago
interval stretching versus dose reduction
comment on genuine question about purity that I am slightly embarrassed to ask in c/coa · 47 points · 1 year ago
redact your own name, not the vendor's batch details
comment on why does nobody talk about related substances in c/coa · 0 points · 1 year ago
area% is not mass%, and here is exactly why it matters
comment on [Vendor] WXT order #13 — the Netherlands, 15 days, no drama, receipts inside in c/tapering · 294 points · 1 year ago
Yeah, regain is not a failure.
comment on my hs-CRP moved and I cannot work out whether Zepbound is why in c/tirzepatide · 64 points · 1 year ago
The confident tone is doing a lot of work that the evidence is not.
Disagree on that part. 99.2% and 99.3% on the same vial is normal.
comment on anyone else notice discontinuation kicking in around week 29 in c/tapering · 94 points · 1 year ago
Yeah, regain is not a failure.
comment on [Meta] the Canada rule is doing its job and people should stop complaining in c/glp1canada · 16 points · 1 year ago
Respectfully this is a sample of one presented as a finding.
comment on the SURPASS thing finally clicked for me and I want to write it down in c/tirzepatide · 37 points · 2 years ago
the GIP side does different things than the GLP-1 side, that is the point
Disagree on that part. 98.7% and 98.9% on the same vial is normal.
comment on [Discussion] can we stop arguing about related substances until somebody posts a number in c/coa · 78 points · 2 years ago
axis labels included, always
comment on [Lab] 13th independent test on BCH, and the trend is the interesting part in c/tirzepatide · 62 points · 2 years ago
the dual agonism hits different and that is why people describe it differently
comment on [Lab] 13th independent test on BCH, and the trend is the interesting part in c/tirzepatide · 154 points · 2 years ago
Vial-splitting is on-topic here. Do not ask about pen-cracking, that goes in c/reconstitution.
comment on [Lab] 8th independent test on BCH, and the trend is the interesting part in c/coa · 5 points · 2 years ago
the method line is doing real work, not just window dressing
comment on [Question] how do you actually verify water content in c/coa · 0 points · 2 years ago
Are you looking at area% or net peptide content? Different numbers.
comment on [Meta] the batch rule is doing its job and people should stop complaining in c/coa · 70 points · 2 years ago
Titration speed is a side-effect dial far more than an efficacy dial.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.